Four companies seeking to secure injunction against drug price cuts

Domestic four drug makers and the government are at odds over the new regulation slashing drug prices by an average of 14 percent from April 1.

The four drug companies, such as Ilsung Pharmaceuticals, Elyson Pharmaceuticals, Dalim BioTech and KMS Pharmaceutical, have filed an injunction and annulment suit against the Ministry of Health and Welfare, claiming the government’s drug pricing ref...